Navigation Links
Spherix Hires Key Employees

BETHESDA, Md., April 17 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX) announced the recent hire of Randy Brown as Chief of Operations. Mr. Brown will be monitoring and overseeing all aspects of the ongoing Phase 3 clinical trial regarding the use of Naturlose(R) as a treatment for Type 2 diabetes. The hiring of Mr. Brown has allowed Spherix to terminate its agreement with the Contract Research Organization (CRO), take over full control of the clinical trial and its pivotal contracts, and build from existing internal resources, rather than outsource to third parties. Mr. Brown has spent 16 years in the pharmaceutical industry, most recently running the operations group for a CRO.

Mr. Brown said, "I am very pleased and excited to join the Spherix staff. Leading the efforts in our clinical program is a wonderful opportunity and I am looking forward to meeting the challenge. Our ability to pull the trials in-house will give us direct control of the program and potentially save us significant dollars. Simply put, it makes good business sense."

Spherix further announced the recent hire of an experienced toxicologist to assist with the many ongoing Health Sciences Consulting projects. This business segment provides technical and regulatory consulting services to several major consumer, food, ingredient, and pharmaceutical companies, and is continuing to grow.

Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on October 10, 2007.

Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in biotechnology, and provides technical and regulatory consulting services to biotechnology and pharmaceutical companies.

Spherix's address is .

SOURCE Spherix Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Reports 2007 Financial Results
2. Spherix Reports 3rd Quarter Earnings
3. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
4. Liberty Screening Services Hires Top Executive to Meet Explosive Demand for its Background-Screening Services
5. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
6. SpectraScience Strengthens Leadership Team With Four Key Hires
7. L&M Healthcare Communications, LLC, Hires Scott Karasinski, PharmD
8. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
9. Medpace Hires Clinical Pharmacologist, Jim Wei, MD, PhD
10. Biomoda Hires Senior Scientist to Expand Research & Development Effort
11. Ventria Expands Team and Hires Kansan as Director of Bioprocessing Operations
Post Your Comments:
(Date:11/26/2015)... England , November 26, 2015 ... an innovative medical device company specializing in imaging technologies, announced ... the European Commission as part of the Horizon 2020 European ... to carry out a large-scale clinical trial in breast cancer. ...      (Logo: , --> ...
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
Breaking Biology Technology:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
(Date:10/26/2015)... and LAS VEGAS , Oct. 26, ... , an innovator in modern authentication and a founding ... the launch of its latest version of the Nok ... organizations to use standards-based authentication that supports existing and ... Authentication Suite is ideal for organizations deploying customer-facing applications ...
Breaking Biology News(10 mins):